NASDAQ:NLTX
Delisted

Neoleukin Therapeutics Stock News

etoro logo Buy NLTX
*Your capital is at risk
$3.49
+0 (+0%)
At Close: Mar 15, 2024
Novo Resources Corp. (“Novo” or the “Company”) (TSX-V: NVO; OTCQX: NSRPF) is pleased to announce that it has exercised its option to earn a 50% interest (the

Novo joins Victorian gold hunt

07:32am, Wednesday, 23'rd Sep 2020
TSX-V listed Novo Resources is set to join the lucrative hunt for gold in Victoria after putting an option in place with Kalamazoo Resources to earn an initial interest in the Queens gold project sout
With its recently acquired Ashburton gold project in Western Australia now gaining greater focus and 10 priority targets in Victoria, Kalamazoo Resources (ASX: KZR) has granted Canada-listed Novo Reso
Novo Resources Corp. (“Novo” or the “Company”) (TSX-V: NVO; OTCQX: NSRPF) is pleased to announce that it has been granted an option and an additional earn-in
The intertwined companies made healthy gains at the end of the week, though the reason for them wasn't immediately evident.
Novo Resources Corp. (“Novo” or the “Company”) (TSX-V: NVO; OTCQX: NSRPF) is pleased to announce that it has signed a binding terms sheet (the “Terms Sheet”)
Novo Nordisk A/S – Share repurchase programme Bagsværd, Denmark, 21 September 2020 – On 6 August 2020, Novo Nordisk initiated a share repurchase programme...
Fmr LLC lessened its holdings in Novo Nordisk A/S (NYSE:NVO) by 24.7% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund own
LAVA Therapeutics Announces $83 million Series C Financing to Advance Novel Immuno-Oncology Programs
Dicerna develops RNAi therapies. Several large-cap pharma companies are collaborators.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE